Working… Menu
Trial record 2 of 3 for:    GT005

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (EXPLORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04437368
Recruitment Status : Recruiting
First Posted : June 18, 2020
Last Update Posted : February 21, 2021
Information provided by (Responsible Party):
Gyroscope Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 28, 2023
Estimated Study Completion Date : February 28, 2024